does tirzepatide cause vision loss macular degeneration NEJM Editorial Fellow Katerina Lin, MD, unpacks the science behind a study on Ozempic and vision loss: GLP-1

M., & Zhang, L

24, the OFA described the decision as reckless and arbitrary and said it will deprive patients of a vital treatment for type 2 diabetes, obesity, cardiovascular disease and other serious medical conditions. The group also alleged that significant issues remain with the supply of these drugs, saying FDA officials acted to benefit special interests. If ever an agency action were arbitrary, capricious, and contrary to law, this is it, the OFA added in its lawsuit

Quantifying the local resolution of cryo-EM density maps

These are not FDA approved and may not be available in your state

Goodwin, DO, Department of Graduate Medical Education, Ocean University Medical Center, Brick Township, New Jersey 08724 ([email protected])